Phalipon; Armelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for Phalipon; Armelle.The latest application filed is for "glycoconjugates and their use as potential vaccines against infection by shigella flexneri".

Company Profile

1.8.12

Phalipon; Armelle - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri Grant 10,376,593 - Mulard , et al. A	2019-08-13
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X Grant 10,087,242 - Mulard , et al. October 2, 2	2018-10-02
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri Grant 9,446,109 - Phalipon , et al. September 20, 2	2016-09-20
Glycoconjugates And Their Use As Potential Vaccines Against Infection By Shigella Flexneri App 20150290331 - Mulard; Laurence ; et al.	2015-10-15
GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X App 20150050282 - MULARD; Laurence ; et al.	2015-02-19
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X Grant 8,815,239 - Mulard , et al. August 26, 2	2014-08-26
Glycoconjugates And Their Use As Potential Vaccines Against Infection By Shigella Flexneri App 20140161793 - PHALIPON; Armelle ; et al.	2014-06-12
Glycoconjugates And Their Use As Potential Vaccines Against Infection By Shigella Flexneri App 20130243751 - PHALIPON; Armelle ; et al.	2013-09-19
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri Grant 8,124,380 - Phalipon , et al. February 28, 2	2012-02-28
Targeting the histone code as a bacterial strategy for selectively modulating gene expression Grant 8,092,989 - Arbibe , et al. January 10, 2	2012-01-10
Targeting the histone code as a bacterial strategy for selectively modulating gene expression App 20100322974 - Sansonetti; Philippe ; et al.	2010-12-23
Glycoconjugates And Use Thereof As Vaccine Against Shigella Flexneri Serotype 3a And X App 20100239584 - Mulard; Laurence ; et al.	2010-09-23
Targeting the Histone Code as a Bacterial Strategy for Selectively Modulating Gene Expression App 20090324646 - Arbibe; Laurence ; et al.	2009-12-31
Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri App 20080112951 - Phalipon; Armelle ; et al.	2008-05-15
Targeting the histone code as a bacterial strategy for selectively modulating gene expression App 20070077254 - Sansonetti; Philippe ; et al.	2007-04-05
Methods for selecting immunogenic polypeptides App 20030124143 - Phalipon, Armelle ; et al.	2003-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.